Stay updated with breaking news from Deb Schrag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A trial found more than nine in ten patients who skipped radiotherapy were just as likely to be alive five years later as those who had it.
Researchers discover bowel cancer patients could skip radiotherapy, if they responded well to chemo.
Neoadjuvant treatment with fluorouracil, leucovorin, and oxaliplatin proved to be as effective as pelvic chemoradiation with fewer adverse effects in patients with locally advanced rectal cancer who were eligible for sphincter-sparing surgery.
Diagnostic Evaluations Were Consistent With GalleriⓇ-Predicted Cancer Signal Origin in 78% of Study Participants Whole-Body Imaging Did Not Contribute to Di ...
Radiation has severe side effects and research found no drop in survival rates for those who did not receive it compared to those who did